EMEA Widening of acceptance limit [Regulatives / Guidelines]

posted by hiren379 – India, 2012-05-02 10:39 (5166 d 19:19 ago) – Posting: # 8486
Views: 5,090

Hello friends,
EMEA states below
"Those HVDP for which a wider difference in Cmax is considered clinically irrelevant based on a sound clinical justification can be assessed with a widened acceptance range."

Is it necessary to give the justification a priori in the protocol for no relevance of wider difference in Cmax. :confused:

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
119 visitors (0 registered, 119 guests [including 10 identified bots]).
Forum time: 05:58 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5